Federico Piacentini - Dissemin

Language
Login

All papers authored by Federico Piacentini

This paper is made freely available by the publisher.

2022 Francesco Caputo

ORCID

, Chiara Santini, Andrea Casadei-Gardini

ORCID

, Krisida Cerma, Camilla Bardasi

ORCID

, Ingrid Garajovà, Elisabetta Lattanzi, Alessandro Passardi

ORCID

, Ilario Giovanni Rapposelli

ORCID

, Andrea Spallanzani

ORCID

, Massimiliano Salati

ORCID

, Luca Reggiani Bonetti

ORCID

, Roberta Gelmini

ORCID

ORCID

, Micaela Piccoli

ORCID

and 6 other authors

Statins increase pathological response in locally advanced rectal cancer treated with chemoradiation: a multicenter experience

Download from doi.org

This paper is made freely available by the publisher.

Camilla Bardasi, Stefania Benatti, Gabriele Luppi, Ingrid Garajovà, Federico Piacentini

ORCID

, Massimo Dominici, Fabio Gelsomino

ORCID

Carcinoid Crisis: A Misunderstood and Unrecognized Oncological Emergency

Download from doi.org

This paper is made freely available by the publisher.

2021 Francesca Matilde Schipilliti, Ingrid Garajová, Giulia Rovesti

ORCID

, Rita Balsano, Federico Piacentini

ORCID

, Massimo Dominici, Fabio Gelsomino

The Growing Skyline of Advanced Hepatocellular Carcinoma Treatment: A Review

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2020 Valentina Guarneri, Maria Vittoria Dieci

ORCID

, Giancarlo Bisagni, Alba A. Brandes, Antonio Frassoldati, Luigi Cavanna

ORCID

, Antonino Musolino

ORCID

, Francesco Giotta

ORCID

, Anita Rimanti, Ornella Garrone

ORCID

, Elena Bertone, Katia Cagossi, Oriana Nanni, Federico Piacentini

ORCID

, Enrico Orvieto and 8 other authors

PIK3CA mutation in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer: association with prognosis and integration with PAM50 subtype.

Upload

This paper is made freely available by the publisher.

2019 Claudia Omarini

ORCID

, Patrizia Palumbo, Annarita Pecchi, Stefano Draisci, Sara Balduzzi

ORCID

, Cecilia Nasso, Monica Barbolini, Chrystel Isca, Alessandro Bocconi, Luca Moscetti

ORCID

, Silvia Galetti

ORCID

, Giovanni Tazzioli

ORCID

, Pietro Torricelli, Stefano Cascinu, Federico Piacentini

ORCID

Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2018 Giorgia Guaitoli, Federico Piacentini

ORCID

, Claudia Omarini, Alessia Andreotti, Enza Palma, Simona Papi, Chiara De Pietri, Andrea Conti

ORCID

, Stefano Cascinu, Giovanni Tazzioli

Post-surgical pyoderma gangrenosum of the breast: needs for early diagnosis and right therapy

Upload

This paper is made freely available by the publisher.

Claudia Omarini, Giorgia Guaitoli, Stefania Pipitone, Luca Moscetti

ORCID

, Laura Cortesi, Stefano Cascinu, Federico Piacentini

ORCID

Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2017 M. V. Dieci, A. Frassoldati, D. Generali, G. Bisagni, F. Piacentini

ORCID

, L. Cavanna, K. Cagossi, F. Puglisi, A. Michelotti, R. Berardi, G. Banna, A. Goubar, G. Ficarra, G. Griguolo, Pierfranco Conte

ORCID

and 1 other authors

Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials

Upload

This paper is available in a repository.

Michela Maur, Claudia Omarini, Federico Piacentini

ORCID

, Annalisa Fontana, Elisa Pettorelli, Stefano Cascinu

Metronomic Capecitabine Effectively Blocks Leptomeningeal Carcinomatosis From Breast Cancer: A Case Report and Literature Review

Download from europepmc.org

This paper was not found in any repository, but could be made available legally by the author.

2016 C. Omarini, C. Caprera, S. Manfredini, F. Caggia, G. Guaitoli, M. E. Filieri, S. R. Bettelli, L. Moscetti, S. Kaleci, A. V. Tamma, S. Cascinu, F. Piacentini

ORCID

Clinical and molecular analysis of long-term HER2 positive metastatic breast cancer survivors

Upload

This paper was not found in any repository, but could be made available legally by the author.

M. E. Filieri, S. R. Bettelli, A. Maiorana, C. Caprera, S. Manfredini, F. Caggia, E. Iattoni, S. Cascinu, C. Omarini, F. Piacentini

ORCID

Molecular profile in primary and metastatic breast cancer treated with Exemestane and Everolimus

Upload

This paper was not found in any repository, but could be made available legally by the author.

E. Lattoni, C. Omarini, A. V. Tamma, S. Noventa, G. Orsi, F. Piacentini

ORCID

, L. Moscetti, S. Cascinu

Pre and post anti Her-2 therapy era: a mono-institutional analysis of the outcome in patients with residual disease after neoadjuvant therapy for Her-2 positive locally advanced breast cancer

Upload

This paper was not found in any repository, but could be made available legally by the author.

C. Omarini, G. Medici, G. Guaitoli, E. Iattoni, L. Moscetti, S. Balduzzi, S. Cascinu, F. Piacentini

ORCID

Safety and efficacy of T-DM1 in HER2 positive metastatic breast cancer patients: a real word experience

Upload

This paper was not found in any repository, but could be made available legally by the author.

Giulia Grisendi, Carlotta Spano, Filippo Rossignoli

ORCID

, Naomi D';souza, Giulia Golinelli

ORCID

, Agnese Fiori, Edwin M. Horwitz, Valentina Guarneri, Federico Piacentini

ORCID

, Paolo Paolucci, Massimo Dominici

Tumor Stroma Manipulation By MSC

Upload

This paper was not found in any repository, but could be made available legally by the author.

Mv Dieci, G. Bisagni, K. Cagossi, Dg Generali, S. Sarti, F. Piacentini

ORCID

, P. Conte, V. Guarneri

Abstract P2-08-03: Survival analysis of the prospective randomized Cher-Lob study: Correlation with tumor infiltrating lymphocytes:

Upload

This paper was not found in any repository, but could be made available legally by the author.

M. V. Dieci, A. Prat, E. Tagliafico, L. Paré, G. Ficarra, G. Bisagni, D. G. Generali, F. Piacentini

ORCID

, P. Conte

ORCID

, V. Guarneri

Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

A. Musolino

ORCID

, N. Naldi, M. V. Dieci, D. Zanoni, A. Rimanti, D. Boggiani, P. Sgargi, D. G. Generali, M. Ambroggi, F. Piacentini

ORCID

, K. Cagossi, L. Gianni, S. Sarti, G. Bisagni, A. Ardizzoni and 2 other authors

Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer

Upload

This paper was not found in any repository, but could be made available legally by the author.

2015 Javier Cortés, Véronique Dieras, Jungsil Ro, Jérôme Barriere, Thomas Bachelot, Sara Hurvitz, Andreas Schneeweiss, Emilie Le Rhun, Joo Hyuk Sohn, Marc Espié, Sung-Bae Kim, Julie Taguchi, Jean-Marc Nabholtz, Pirkko-Liisa Kellokumpu-Lehtinen, Eva Ciruelos and 5 other authors

Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): a randomised, open-label, multicentre, phase 2 trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

Luca Roncati, Giuseppe Barbolini, Federico Piacentini

ORCID

, Francesco Piscioli, Teresa Pusiol, Antonio Maiorana

ORCID

Prognostic Factors for Breast Cancer: an Immunomorphological Update

Upload

This paper was not found in any repository, but could be made available legally by the author.

Maria Vittoria Dieci, Giancarlo Bisagni, Katia Cagossi, Alberto Bottini, Samanta Sarti, Federico Piacentini

ORCID

, Pierfranco Conte, Valentina Guarneri

Abstract PD1-1: Tumor infiltrating lymphocytes and correlation with outcome in the Cher-LOB study:

Upload

Missing publications? Search for publications with a matching author name.